Comparative mRNA Expression of eEF1A Isoforms and a PI3K/Akt/mTOR Pathway in a Cellular Model of Parkinson’s Disease
The PI3K/Akt/mTOR pathway is one of dysregulated pathways in Parkinson’s disease (PD). Previous studies in nonneuronal cells showed that Akt regulation can be increased by eukaryotic protein elongation factor 1 alpha 2 (eEF1A2). eEF1A2 is proposed to contribute protection against apoptotic death, li...
Saved in:
Main Authors: | Kawinthra Khwanraj, Suriyat Madlah, Khwanthana Grataitong, Permphan Dharmasaroja |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2016/8716016 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas
by: Juan Du, et al.
Published: (2016-01-01) -
The Clinical and Prognostic Significance of Activated AKT-mTOR Pathway in Human Astrocytomas
by: Elias A. El Habr, et al.
Published: (2012-01-01) -
Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3K/AKT/mTOR pathway
by: Adrish Sen, et al.
Published: (2025-01-01) -
Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
by: Athanasia Pavlidou, et al.
Published: (2014-01-01) -
TEEG Induced A549 Cell Autophagy by Regulating the PI3K/AKT/mTOR Signaling Pathway
by: Lu Shi, et al.
Published: (2019-01-01)